12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Vical completes follow-on

Vical Inc. (NASDAQ:VICL), San Diego, Calif.
Business: Cancer, Infectious, Gene/Cell therapy
Date...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >